Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer (Q85002519)
Jump to navigation
Jump to search
scientific article published on 27 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer |
scientific article published on 27 September 2011 |
Statements
Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer (English)
Manish Gupta
Patricia M Lorusso
Bei Wang
Joo-Hee Yi
Howard A Burris
Muralidhar Beeram
Yu-Waye Chu
Samuel Agresta
Barbara Klencke
Amita Joshi
Sandhya Girish
27 September 2011